000			01682 a2200457 4500
005			20250515160819.0
264		0	_c20090707
008			200907s 0 0 eng d
022			_a1879-0712
024	7		_a10.1016/j.ejphar.2009.02.012 _2doi
040			_aNLM _beng _cNLM
100	1		_aLuo, Qingqiong
245	0	0	_aVasoactive intestinal peptide attenuates concanavalin A-mediated liver injury. _h[electronic resource]
260			_bEuropean journal of pharmacology _cApr 2009
300			_a226-33 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aChemical and Drug Induced Liver Injury _xphysiopathology
650	0	4	_aConcanavalin A _xtoxicity
650	0	4	_aCyclic AMP _xmetabolism
650	0	4	_aDisease Models, Animal
650	0	4	_aGene Expression Regulation
650	0	4	_aHepatocytes _xdrug effects
650	0	4	_aInterferon-gamma _xdrug effects
650	0	4	_aInterleukin-10 _xmetabolism
650	0	4	_aLiver _xdrug effects
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aReceptors, Vasoactive Intestinal Polypeptide, Type I _xmetabolism
650	0	4	_aTransaminases _xdrug effects
650	0	4	_aTumor Necrosis Factor-alpha _xdrug effects
650	0	4	_aVasoactive Intestinal Peptide _xadministration & dosage
700	1		_aWang, Ying
700	1		_aFeng, Dechun
700	1		_aXu, Yan
700	1		_aXu, Lingyun
773	0		_tEuropean journal of pharmacology _gvol. 607 _gno. 1-3 _gp. 226-33
856	4	0	_uhttps://doi.org/10.1016/j.ejphar.2009.02.012 _zAvailable from publisher's website
999			_c18665838 _d18665838